American Association for Cancer Research

SHERPA: White

People

  1. Rosen
    Rosen
  2. Scher
    Scher
  3. Ladanyi
    Ladanyi
  4. Solit
    Solit
  5. De Stanchina
    De Stanchina
  6. Houghton
    Houghton
  7. Cheung
    Cheung
  8. Orlow
    Orlow
  9. Kris
    Kris
  10. Sirotnak
    Sirotnak

Groups

  1. Department of Medicine (759)
  2. GSK Faculty (569)
  3. Solid Tumor Oncology Division (542)
  4. Sloan Kettering Institute Faculty (386)
  5. Sloan Kettering Institute Postdocs (266)
  6. Surgery (257)
  7. Epidemiology and Biostatistics (240)
  8. Population Sciences Research Program (236)
  9. Molecular Pharmacology and Chemistry Program Faculty (221)
  10. Center for Hematologic Malignancies (218)
Search Within
Formats
  1. Meeting Abstract (1046)
  2. Journal Article (782)
  3. Editorial (36)
  4. Review (27)
Groups
  1. Department of Medicine (759)
  2. GSK Faculty (569)
  3. Solid Tumor Oncology Division (542)
  4. Sloan Kettering Institute Faculty (386)
  5. Sloan Kettering Institute Postdocs (266)
  6. Surgery (257)

More Groups

People
  1. Joseph Bertino (93)
  2. Neal Rosen (70)
  3. Howard Scher (58)
  4. Carlos Cordon-Cardo (54)
  5. Debabrata Banerjee (47)
  6. Marc Ladanyi (44)

More People

Years
  1. 2025 (32)
  2. 2024 (63)
  3. 2023 (65)
  4. 2022 (71)
  5. 2021 (62)
  6. 2020 (85)

More Years

Publications
  1. Proceedings of the American Association for Cancer Research Annual Meeting (924)
  2. Cancer Discovery (294)
  3. Cancer Epidemiology Biomarkers and Prevention (249)
  4. Molecular Cancer Therapeutics (124)
  5. Cancer Immunology Research (103)
  6. Molecular Cancer Research (68)

More Publications

Results (1891)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Community partnerships expand access to tumor molecular profiling
    Meeting Abstract

    Reynolds, T.; Jack, K.; Kemeny, M.; Bulone, L.; Gonsky, J.; Kampel, L. J.; Hyman, D.; Solit, D. B.; Conklin, C.; McMillan, S.; more...
    Cancer Epidemiology Biomarkers and Prevention (2020)

    Fulltext@MSK | Save
  • Concurrent targeting of potential cancer stem cells regulating pathways sensitizes lung adenocarcinoma to standard chemotherapy
    Journal Article

    Shibata, M.; Ooki, A.; Inokawa, Y.; Sadhukhan, P.; Ugurlu, M. T.; Izumchenko, E.; Munari, E.; Bogina, G.; Rudin, C. M.; Gabrielson, E.; more...
    Molecular Cancer Therapeutics (2020)

    Fulltext@MSK | Save
  • An in vivo KRAS allelic series reveals distinct phenotypes of common oncogenic variants
    Journal Article

    Zafra, M. P.; Parsons, M. J.; Kim, J.; Alonso-Curbelo, D.; Goswami, S.; Schatoff, E. M.; Han, T.; Katti, A.; Calvo Fernandez, M. T.; Wilkinson, J. E.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • PRMT5 inhibition modulates E2F1 methylation and gene-regulatory networks leading to therapeutic efficacy in JAK2(V617F)-mutant MPN
    Journal Article

    Pastore, F.; Bhagwat, N.; Pastore, A.; Radzisheuskaya, A.; Karzai, A.; Krishnan, A.; Li, B.; Bowman, R. L.; Xiao, W.; Viny, A. D.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Activating alterations of p110 subunits determine PI3K isoform selectivity in prostate cancer
    Meeting Abstract

    Zhang, Z.; Mao, N.; Lee, Y. S.; Li, D.; Rosen, N.; Sawyers, C.; Carver, B.
    Molecular Cancer Research (2020)

    Fulltext@MSK | Save
  • Single-arm, open-label, phase II study of LY3023414 for the treatment of recurrent or persistent endometrial cancer
    Meeting Abstract

    Rubinstein, M. M.; Hyman, D.; Caird, I.; O'Cearbhaill, R.; Grisham, R.; Tew, W.; Hensley, M.; Sabbatini, P.; Aghajanian, C.; Iasonos, A.; more...
    Molecular Cancer Research (2020)

    Fulltext@MSK | Save
  • Single-cell multiplex immunofluorescence of formalin-fixed, paraffin-embedded prostate cancer tissue identifies PI3K pathway activation in two prospective cohort studies
    Meeting Abstract

    Stopsack, K. H.; Huang, Y.; Tyekucheva, S.; Gerke, T. A.; Bango, C.; Elfandy, H.; Gao, X.; Cai, Z.; Roberts, T. M.; Kantoff, P. W.; more...
    Molecular Cancer Research (2020)

    Fulltext@MSK | Save
  • Developmentally regulated mTOR degradation in normal and malignant hematopoiesis
    Meeting Abstract

    Spevak, C. C.; Elias, H. K.; Kannan, L.; Martin, G.; Selvaraj, S.; Eng, W. S.; Ernlund, A.; Rajasekhar, V. K.; Woolthuis, C. M.; Schneider, R. J.; more...
    Molecular Cancer Research (2020)

    Fulltext@MSK | Save
  • AKT mutant allele-specific activation dictates pharmacologic sensitivities
    Meeting Abstract

    Shrestha Bhattarai, T.; Shamu, T.; Patel, S.; Gorelick, A.; Chang, M. T.; Gavrila, E. I.; Gao, J. J.; Donoghue, M. T. A.; Gao, P. S.; Soumerai, T.; more...
    Molecular Cancer Research (2020)

    Fulltext@MSK | Save
  • Compound PIK3CA mutations support a mutational dose-response model for oncogene activation and response to PI3K inhibitor targeted therapy in breast cancer
    Meeting Abstract

    Vasan, N.; Johnson, J.; Shao, H.; Razavi, P.; Gorelick, A.; Ladewig, E.; Antoine, A.; Shah, H.; Toska, E.; Xu, G.; more...
    Molecular Cancer Research (2020)

    Fulltext@MSK | Save